Undeclared Yohimbine Sparks Recall of SUPPLX Business Pill, Branch Manager 2026

Severe hypertension, irregular heartbeat, and even heart attacks are among the dangers now linked to two popular men’s supplements sold online. SUPPLX.com has issued a voluntary nationwide recall of its ‘Business Pill’ and ‘Branch Manager for Men’ products after FDA laboratory testing confirmed that both contain undeclared yohimbine, a potent plant-derived alkaloid not listed anywhere on the product labels.

The Grant-Valkaria, Florida-based company markets both items as dietary supplements for male sexual enhancement. According to the FDA-posted announcement, laboratory analysis found dangerously high levels of yohimbine in the products, a substance typically reserved for prescription use in treating erectile dysfunction and sometimes studied for blood flow or athletic performance support.

Products Affected by This Recall

The recall covers ‘Business Pill’ and ‘Branch Manager for Men,’ both sold through SUPPLX.com in single-capsule blister cards packaged inside 24-count retail boxes. Every lot and every expiration or best-by date distributed between September 16, 2023, and June 11, 2026, is included in the recall – meaning consumers cannot rely on a specific batch number to determine if their product is safe.

Lot and expiration information can be found on the back of each individual blister card. On ‘Business Pill,’ it is printed in the upper-right corner; on ‘Branch Manager for Men,’ it sits directly above the barcode. No other SUPPLX.com products are affected by this action.

What Went Wrong?

If you take either supplement, you should understand exactly what you may be exposed to. Yohimbine is not a mild ingredient – the FDA warns it can cause severe hypertension, tachycardia, and possibly cardiac arrhythmia or myocardial infarction, especially dangerous for anyone also using caffeine, ephedra-containing products, or ADHD medications.

Beyond cardiac risks, high doses can trigger severe gastrointestinal distress including nausea, vomiting, diarrhea, and stomach pain. The FDA also cautions that yohimbine can cause acute neurologic and psychiatric effects such as anxiety, insomnia, mania, psychosis in schizophrenic patients, drowsiness, disorientation, tremors, and seizures. In cases of severe overdose, death has been reported.

Who Should Be Concerned

Because the products were sold nationwide through SUPPLX.com’s website, anyone across the country who purchased ‘Business Pill’ or ‘Branch Manager for Men’ since late 2023 could be affected. Men using these supplements alongside stimulants, prescription heart medications, or ADHD drugs face heightened risk and should treat this recall as a priority.

What Consumers Need to Do Now

SUPPLX.com says it is notifying affected customers directly, but the company is also urging the general public to act without waiting for individual contact. Anyone who owns either product should stop using it immediately and dispose of any remaining capsules.

• Stop taking ‘Business Pill’ or ‘Branch Manager for Men’ right away.
• Dispose of any unused product still in your possession.
• Contact a physician or health care provider if you have experienced symptoms possibly linked to use.
• Reach out to SUPPLX Recall at (321) 341-9501 or SupplxRecall@gmail.com with questions.
• Report adverse events to the FDA’s MedWatch program online or by fax at 1-800-FDA-0178.

From the Agency

The company announcement, dated September 3, 2026, and published by the FDA on September 4, 2026, states that the recall ‘is being conducted with the knowledge of the U.S. Food and Drug Administration.’ As with all company-issued recalls posted to its site, the FDA notes it does not endorse the product or the company, but shares the notice as a public safety service.

Consumers who purchased either supplement are encouraged to check the lot information on their blister cards immediately and follow the disposal and reporting steps outlined above, rather than waiting for direct notification to arrive.